Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Citius Pharmaceuticals Inc (CTXR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Citius Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.726 -0.020    -2.68%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
0.722
-0.004
-0.537%
17:38:27 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 533,141
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.720 - 0.744
Citius Pharma 0.726 -0.020 -2.68%

Citius Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Citius Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

22

Equity Type

ORD

Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives products in adjunct cancer care, prescription products, and stem cell therapy. It is developing five proprietary products comprising LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma, which is in Phase 3 clinical trial; Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase 3 clinical trial; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids that is in clinical Phase 2b trial; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. The company was founded in 2007 and is headquartered in Cranford, New Jersey.

Contact Information

Address 11 Commerce Drive First Floor
Cranford, 07016
United States
Phone 908 967 6677
Fax -

Top Executives

Name Age Since Title
Suren G. Dutia 81 2015 Independent Director
Leonard L. Mazur 79 2014 Co-Founder, CEO, Chairman & Secretary
Carol A. Webb 77 2016 Independent Director
Myron Z. Holubiak 77 2015 Co-Founder & Executive Vice Chairman
Mark Rupp - - Member of Scientific Advisory Board
Leonard A. Mermel - 2018 Member of Scientific Advisory Board
Issam Raad - - Chairman of Scientific Advisory Board
Perenlei Enkhbaatar - - ARDS Scientific Advisory Board Member
Eugene Holuka 65 2016 Independent Director
John G. Laffey - 2021 ARDS Scientific Advisory Board Member
Mitchell M. Levy - - ARDS Scientific Advisory Board Member
Dennis M. McGrath 67 2023 Independent Director
Lorraine B. Ware - - ARDS Scientific Advisory Board Member
Michael A. Matthay - - ARDS Scientific Advisory Board Member
Joel Rosenblatt - - Member of Scientific Advisory Board
Robert J. Smith 63 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CTXR Comments

Write your thoughts about Citius Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
okan yıldırım
okan yıldırım Sep 25, 2023 11:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think the company went bankrupt
GÖKHAN BALCI
GÖKHAN BALCI Jul 20, 2023 11:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will fly very soon
Feed Seow
Feed Seow Apr 07, 2022 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I’m in too, its undervalue
Michael miki
Michael miki Jul 01, 2021 4:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I just jumped in today !
Robert Feifer
Robert Feifer Jun 28, 2021 2:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
long term lotto ffhl
Luca Ronconi
Luca Ronconi Jun 25, 2021 9:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
russel 2000 and phase 3 results next week, even if we see a correction today i'm not slightly worried. long on citius, i've done some deep DD and i am leaving my money in there for a good year at the very least
Viras Prom
Viras Prom Jun 25, 2021 9:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I need more time for my transanction then buy more stuff. Long term is incredible due to great stock.
Neek Kajula
Neek Kajula Jun 23, 2021 9:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice bounce back, hopefully no one sold the dip in panic
Viras Prom
Viras Prom Jun 22, 2021 11:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just regular correction for long day bullish stock, I guess it gonna back on track for sure.
Neek Kajula
Neek Kajula Jun 21, 2021 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
To quote a value investing mastermind, I like the stock
Brett Ballendine
Brett Ballendine Jun 18, 2021 2:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sorry guys. just bought in. that's why it sunk on you. my bad.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email